ArticleBioinformatics (Oxford, England)2025
Predicting the trend of SARS-CoV-2 mutation frequencies using historical data.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
motivationAs the SARS-CoV-2 virus rapidly evolves, predicting the trajectory of viral mutations has become a critical yet complex task. A deep understanding of future mutation patterns, in particular the mutations that will prevail in the near future, is vital in steering diagnostics, therapeutics, and vaccine strategies for disease control.
resultsIn this study, we developed a model to forecast future SARS-CoV-2 mutation surges in real-time, using historical mutation frequency data from the USA. We transformed the temporal prediction problem into a supervised learning framework using a sliding window approach. This involved breaking the time series of mutation frequencies into very short segments. Considering the time-dependent nature of the data, we focused on modeling the first-order derivative of the mutation frequency. We predicted the final derivative in each segment based on the preceding derivatives, employing various machine learning methods, including random forest, XGBoost, support vector machine, and neural network models. Empowered by the novel transformation strategy and the high capacity of machine learning models, we observed low prediction error that is confined within 0.1% and 1% when making predictions of mutation rates for the future 30 and 80 days, respectively. In addition, the method also led to a notable increase in prediction accuracy compared to traditional time-series models, as evidenced by much lower MAE (Mean Absolute Error) and MSE (Mean Squared Error) for predictions made within different time horizons. To further assess the method's effectiveness and robustness in predicting mutation patterns for unforeseen mutations, we first designed a synthetic case where we categorized all mutations into three major patterns. The model demonstrated its robustness by accurately predicting unseen mutation patterns when training on data from two pattern categories while testing on the third pattern category, showcasing its potential in forecasting a variety of mutation trajectories. We then applied our method to prediction for a recent time frame between 1 January 2025 and 10 June 2025, for both the USA and UK, where the model training was conducted using frequency sequence data collected between 12 December 2019 and 26 January 2023 in the USA. The model demonstrated superior performance for both datasets. AVAILABILITY AND IMPLEMENTATION: To enhance accessibility and utility, we built our methodology into a GitHub package (https://github.com/ZhouXY199502/SWD). Our method has the potential applicability to study other infectious diseases or forecasting tasks, thus extending its relevance beyond the current COVID pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.